The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX:
TGODF), a cannabis-focused research and development (“R&D”) today reported
the voting results from its annual general and special meeting of shareholders
of the company which took place in Mississauga, Ontario on December 6, 2018.
The matters up for consideration, which were detailed in the company’s
management information circular dated November 7, 2018, received majority votes
at the meeting, thus approving all matters. Additionally, the shareholders
approved the election of all the nominated directors. Detailed voting results
for the meeting together, as well as a copy of each of the new share option
plan, the new restricted unit plan and the new non-employee directors deferred
units are available under the company’s profile at www.SEDAR.com.
“We are thrilled with the overwhelming support from
shareholders at our AGM,” TGODF Chairman of the Board Jeff Scott stated in the
news release. “2019 will be a pivotal year as TGOD’s flagship domestic
facilities begin production ramp-up and sales commence in the coming weeks.
With over $450 million raised, TGOD has established itself as a leader in
Canadian and international cannabis markets with differentiated premium
all-natural organic product, continued expansion across Europe and Latin
America, and a team with over 200 years of CPG experience including a proven
track record and ability to execute. I have the utmost confidence in our team
as we solidify our organic leadership position and deliver on our goal of
becoming the largest organic cannabis brand in the world.”
To view the full press release, visit http://ibn.fm/9wxmS
About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. is a premium global
organic cannabis company, with operations focused on legal medical cannabis
markets in Canada, Europe and Latin America and the legal Canadian adult-use
market. The company grows high quality, organic cannabis with sustainable,
all-natural principles. TGOD’s products are laboratory tested to ensure
patients have access to a standardized, safe and consistent product. TGOD has a
funded capacity of 170,000 kg and is building 1,382,000 sq. ft. of cultivation
facilities across Ontario, Quebec and Jamaica. In addition, TGOD
has raised approximately C$460 million and has over 20,000 shareholders. TGOD’s
Common Shares and warrants issued under the indenture dated November 1, 2017
trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively. For more
information, visit the company’s website at www.TGOD.ca.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets, these
posts are designed to inform you on the latest happenings of our clients and
other publicly traded companies on our radar. From earnings, acquisitions and
agreements to conference attendance and clinical study results, our news breaks
keep you up-to-date with the day’s top movers. MissionIR is primarily focused
on strategic communications. We have executed countless communications programs
to address the needs of companies ranging from start-ups to established
industry leaders, gaining valuable experience and the expertise necessary to
determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
